Maintenance Therapy With Trabectedin Versus Observation After First Line Treatment With Doxorubicin of Patients With Advanced or Metastatic Soft Tissue Sarcoma.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Trabectedin (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 23 Aug 2017 Planned End Date changed from 1 Apr 2020 to 1 Aug 2019.
- 23 Aug 2017 Planned primary completion date changed from 1 Apr 2019 to 1 Aug 2019.
- 23 Aug 2017 Status changed from not yet recruiting to recruiting.